Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07000019 · ClinicalTrials.gov registry record · NA
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
A NA study, sponsored by New York Medical College.
- Not yet
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07000019 is a NA study that has not yet begun recruiting, run by New York Medical College. The registered enrollment target is 28 participants.
The verdict
NCT07000019, a NA study, has not yet begun recruiting, sponsored by New York Medical College.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are: * To determine the extent to which this combined treatment can improve language. * To determine the extent to which the combined treatment can improve arm movements. Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Interventions
- BEHAVIORAL CARAT: combined aphasia and robot-assisted arm therapy
- BEHAVIORAL Robot-assisted arm therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-06 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07000019
The ClinicalTrials.gov registry entry for NCT07000019 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Medical College, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CARAT: combined aphasia and robot-assisted arm therapy is the first listed.
NCT07000019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07000019 about?
NCT07000019 is a clinical study titled "Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors". The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are: * To determine the extent to which this combined treatment can improve language. * T...
What is the current status of trial NCT07000019?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2025-06. Estimated completion is 2027-11.
What interventions are being tested in trial NCT07000019?
The interventions under investigation include: CARAT: combined aphasia and robot-assisted arm therapy (BEHAVIORAL), Robot-assisted arm therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07000019?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.